Oncology
CYVOLIENT 500
Injection — 500mg/vial
WHO-GMP
Product Overview
Cyclophosphamide for Injection, USP (500mg/vial) is used for intravenous administration to treat various cancers, including malignant lymphomas, leukemia, multiple myeloma, and breast cancer
Indications
Cyclophosphamide for Injection USP, 500mg, is an alkylating drug indicated for treating various malignant diseases, including Hodgkin’s and non-Hodgkin’s lymphomas, multiple myeloma, leukemias (CLL, acute/chronic granulocytic), mycosis fungoides, neuroblastoma, ovarian adenocarcinoma, and breast carcinoma
Dosage Forms & Strength
Available Forms
Injection
Strength
500mg/vial
Regulatory Approvals
WHO-GMP